I've got no idea about the Vet side of this company. However if...

I've got no idea about the Vet side of this company. However if you think there's a chance of getting an FDA approval for their lead compound EBC-46, then your pretty much dreaming. It's never going to be taking seriously by big pharma, especially when it's being used to treat animals.

Also a cancer drug on the ASX in Phase 1 study is worth no more than 20 million max in this current market.

"a drug that gets to phase 2" can be worth US$600 - $800million"

Utter rubbish, maybe a hyped up Nasdaq Oncology company in Phase 3 trials, with a rich pipeline. Certainly not a one trick pony.

Have a look at the other ASX listed Cancer/ Oncology company's before you even go thinking about this highly speculative investment.